Dr. Manus Rogan, Ph.D, MBA

About

Dr. Manus Rogan is a Managing Partner and co-founder of Fountain Healthcare Partners. He has over 27 years of investment and operating experience in the life science sector in both the US and Europe. Manus began his career in product development at GlaxoSmithkline in the UK and later joined Elan Corporation’s business development group, where he was responsible for licensing products and drug delivery technologies in Europe and Japan. In 2001, Manus joined Elan’s Corporate Venture Capital group in New York, investing in private and public biotechnology companies, including Sirna (acquired by Merck) and Beyond Genomics (IPO). He concluded over twenty-five investment and technology licensing transactions involving companies in the US, Europe and Japan during his 7 years at Elan. Manus earned a PhD in chemistry from the University of York (sponsored by GlaxoSmithKline) and an MBA from Trinity College Dublin. He currently serves on the boards of Priothera ltd and Neuromod Devices. He was formerly Chairman of the Irish Venture Capital Association (‘IVCA’) and previously represented Fountain on the boards of Amarin Corporation, Opsona Therapeutics, Inflazome (sold to Roche) and Mainstay Medical (IPO). In addition to his investing role, Manus leads investor relations and fund raising activities for the Fund.